How is the Lexeo Therapeutics Inc. today?

The Lexeo Therapeutics Inc. today is trading in the down by -5.23% at 2.72.

What is Lexeo Therapeutics Inc. Annual Net Profit?

Lexeo Therapeutics Inc. Annual Net Profit fell 48.11% in the last year to $98.33 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Lexeo Therapeutics Inc. Price to Earning Ratio?

Lexeo Therapeutics Inc. Price to Earning Ratio is -0.83, which is negative.

What is Lexeo Therapeutics Inc. Stock Price?

Lexeo Therapeutics Inc. Stock Price fell 83.64% and underperformed its sector by 139.11% in the past year.

What is Lexeo Therapeutics Inc. Quarterly Net profit?

Lexeo Therapeutics Inc. Quarterly Net profit fell 50.61% YoY to $32.66 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Lexeo Therapeutics Inc. Debt to Equity Ratio?

Lexeo Therapeutics Inc. Debt to Equity Ratio of 0.08 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Lexeo Therapeutics Inc. Return on Equity(ROE)?

Lexeo Therapeutics Inc. Return on Equity(ROE) for the last financial year was -85.37%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Lexeo Therapeutics Inc. Mutual Fund Holding?

Lexeo Therapeutics Inc. Mutual Fund Holding decreased by 0.18% in the last quarter to 26.36.

What is Lexeo Therapeutics Inc. Interest Coverage Ratio?

Lexeo Therapeutics Inc. Interest Coverage Ratio is -716.76, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Lexeo Therapeutics Inc. Institutional Holding?

Lexeo Therapeutics Inc. Institutional Holding decreased by 5.74% in the last quarter to 80.4.

Lexeo Therapeutics Inc. XNAS: LXEO

Lexeo Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Lexeo Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Lexeo Therapeutics Inc.
Rating: 0.78208325
Author: Trendlyne DVM scores

about

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene thera...

2.72 -0.15 (-5.23%)

86.05% Fall from 52W High

371.0K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

12.3 / 100

Technically Bearish

19.0 / 100

No estimates available

Lexeo Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lexeo Therapeutics Inc. FAQ

How is Lexeo Therapeutics Inc. today?

Lexeo Therapeutics Inc. today is trading in the red, and is down by -5.23% at 2.72.

How has Lexeo Therapeutics Inc. performed historically?

Lexeo Therapeutics Inc. is currently trading down -5.23% on an intraday basis. In the past week the stock fell -3.55%. stock has been down -4.90% in the past quarter and fell -83.64% in the past year. You can view this in the overview section.